Pampalakis
Pampalakis
Άγνωστη συνεργασία
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα upatras.gr
ΤίτλοςΠαρατίθεται απόΈτος
Functional roles of human kallikrein-related peptidases
G Sotiropoulou, G Pampalakis, EP Diamandis
Journal of Biological Chemistry 284 (48), 32989-32994, 2009
1882009
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
G Sotiropoulou, G Pampalakis, E Lianidou, Z Mourelatos
Rna 15 (8), 1443-1461, 2009
1622009
Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression
IP Michael, G Sotiropoulou, G Pampalakis, A Magklara, M Ghosh, ...
Journal of Biological Chemistry 280 (15), 14628-14635, 2005
1572005
Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer
G Pampalakis, G Sotiropoulou
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1776 (1), 22-31, 2007
1512007
Direct, electronic microRNA detection for the rapid determination of differential expression profiles
H Yang, A Hui, G Pampalakis, L Soleymani, FF Liu, EH Sargent, ...
Angewandte Chemie International Edition 48 (45), 8461-8464, 2009
1212009
Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression
IP Michael, G Pampalakis, SD Mikolajczyk, J Malm, G Sotiropoulou, ...
Journal of Biological Chemistry 281 (18), 12743-12750, 2006
1182006
Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line
E Markoutsa, G Pampalakis, A Niarakis, IA Romero, B Weksler, ...
European journal of pharmaceutics and biopharmaceutics 77 (2), 265-274, 2011
1142011
Down-regulation of dicer expression in ovarian cancer tissues
G Pampalakis, EP Diamandis, D Katsaros, G Sotiropoulou
Clinical biochemistry 43 (3), 324-327, 2010
1082010
The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family
FX Gomis-Rüth, Á Bayés, G Sotiropoulou, G Pampalakis, T Tsetsenis, ...
Journal of Biological Chemistry 277 (30), 27273-27281, 2002
902002
Direct profiling of cancer biomarkers in tumor tissue using a multiplexed nanostructured microelectrode integrated circuit
Z Fang, L Soleymani, G Pampalakis, M Yoshimoto, JA Squire, EH Sargent, ...
ACS nano 3 (10), 3207-3213, 2009
882009
A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition
G Pampalakis, E Prosnikli, T Agalioti, A Vlahou, V Zoumpourlis, ...
Cancer research 69 (9), 3779-3787, 2009
882009
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers
M Sidiropoulos, G Pampalakis, G Sotiropoulou, D Katsaros, ...
Tumor Biology 26 (6), 324-336, 2005
782005
pH-responsive hydrogel/liposome soft nanocomposites for tuning drug release
MT Popescu, S Mourtas, G Pampalakis, SG Antimisiaris, C Tsitsilianis
Biomacromolecules 12 (8), 3023-3030, 2011
772011
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue
M Canovi, E Markoutsa, AN Lazar, G Pampalakis, C Clemente, F Re, ...
Biomaterials 32 (23), 5489-5497, 2011
622011
Targeting the kallikrein-related peptidases for drug development
G Sotiropoulou, G Pampalakis
Trends in pharmacological sciences 33 (12), 623-634, 2012
612012
Emerging interest in the kallikrein gene family for understanding and diagnosing cancer
G Sotiropoulou, V Rogakos, T Tsetsenis, G Pampalakis, N Zafiropoulos, ...
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 13 …, 2003
582003
Evolutionary history of tissue kallikreins
A Pavlopoulou, G Pampalakis, I Michalopoulos, G Sotiropoulou
PLoS One 5 (11), e13781, 2010
542010
Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer
G Pampalakis, G Sotiropoulou
Biological chemistry 387 (6), 773-782, 2006
532006
Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation
G Sotiropoulou, G Pampalakis
Biological chemistry 391 (4), 321-331, 2010
482010
KLK5 inactivation reverses cutaneous hallmarks of Netherton syndrome
L Furio, G Pampalakis, IP Michael, A Nagy, G Sotiropoulou, A Hovnanian
PLoS genetics 11 (9), e1005389, 2015
432015
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20